Co-Diagnostics Inaugurates Manufacturing Facility for New Molecular Diagnostic Test
The facility has been designed to manufacture the company’s Co-Dx Pro instrument and test cups for the new platform.
The facility has been designed to manufacture the company’s Co-Dx Pro instrument and test cups for the new platform.
Key Proteo has initiated plans to build a new CLIA-certified laboratory as part of its growth strategy to enhance newborn screening programs.
Myriad Genetics completed the acquisition of select assets from Intermountain Precision Genomics' laboratory business.
RetinalGeniX Technologies Inc., has contracted with MEDsan, Inc. to provide diagnostic testing...
Read MoreRhode Island Primary Care Physicians Corporation, has announced its partnership with technology and care delivery company, Akido Labs.
Read MoreIllumina will divest GRAIL after a federal appeals court upheld an FTC ruling that it should unwind its deal with GRAIL.
Read MoreSeegene will distribute Microbix’s Quality Assessment Products to monitor the workflow accuracy of Seegene Novaplex and Allplex assays.
Read MoreLighthouse Lab Services acquired Alternative Biomedical Solutions, a lab services company focused on instrument procurement and servicing.
Read MoreCarterra and ENPICOM are collaborating to streamline the analysis of growing sequencing and antibody screening data generated in the lab.
Read MorePerkinElmer’s acquisition of Covaris aims to help expand PerkinElmer’s life sciences portfolio into the high-growth diagnostics end market.
Read MorePersonalis and Tempus Labs announced a collaboration to co-commercialize a whole genome-based liquid biopsy LDT for MRD and cancer detection.
Read MoreTriCore’s partnership expands Atalan’s network of clinical labs seeking to improve patient diagnostics and care while also sharing capacity.
Read MorePhilips and NYU Langone Health has announced an 8-year strategic partnership aimed at enhancing patient care through further innovation.
Read MoreBD has announced that Ronald Silverman, MD, FACS, has been named executive VP and chief medical officer of BD, effective Dec. 4, 2023.
Read MorePrinciple Health Systems has announced the strategic acquisition of BioStat Laboratory, a Dallas-based laboratory.
Read MoreLabcorp announced the completion of a laboratory agreement with Legacy Health to acquire select assets of Legacy’s outreach lab business.
Read MoreThe grant will be used for the development and validation of a custom protein biomarker panel to measure Parkinson’s disease activity.
Read MoreGeneoscopy’s multi-target stool RNA (mt-sRNA) biomarker panel is designed to detect precancerous lesions and colorectal cancer.
Read More